Form 4: Colgate-Palmolive Executive Sally Massey Sells 8,000 Shares
SEC Form 4 Filing
Sally Massey, Chief Human Resources Officer of Colgate-Palmolive, sold 8,000 shares of common stock at an average price of $92.019 on February 25, 2025.
Summary
- On February 25, 2025, Sally Massey, the Chief Human Resources Officer of Colgate-Palmolive, sold 8,000 shares of the company's common stock.
- The shares were sold at a weighted average price of $92.019 per share, with individual transactions ranging from $92.01 to $92.02.
- Following the transaction, Massey directly owns 14,805 shares of Colgate-Palmolive common stock.
- She also indirectly owns 7,865 shares through the Issuer's 401(k) Plan Trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing for an executive stock sale, which is a neutral event. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning rather than a reflection of the company's performance. It's important to consider the overall context of insider trading activity, including buying and selling trends, to gain a more comprehensive understanding.
Comparison to Industry Standards
- Executive stock sales are a normal part of corporate compensation and financial planning.
- Comparing Massey's transactions to those of executives at similar companies like Procter & Gamble (PG) or Unilever (UL) would provide context on the scale and frequency of such sales.
- Analyzing the ratio of executive stock sales to total compensation can also offer insights into alignment with shareholder interests.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of stock sale transaction |
| 02/27/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.